Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Miller

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
The Lancet. Infectious Diseases|September 26, 2025
Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trialKirsten E Lyke, Andrea A Berry, Matthew B Laurens, et al.
Gynecologic Oncology|January 24, 2025
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258Aine Clements, Danielle Enserro, Kyle C Strickland, et al.
The Journal of Infectious Diseases|December 20, 2011
A simplified intravenous artesunate regimen for severe malariaPeter Gottfried Kremsner, Terrie Taylor, Saadou Issifou, et al.
The Lancet. Oncology|April 6, 2019
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trialKathleen N Moore, Angeles Alvarez Secord, Melissa A Geller, et al.
Mutagenesis|September 7, 2018
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?Alexander Amberg, Lennart T Anger, Joel Bercu, et al.
Journal of Clinical Microbiology|June 7, 2003
Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigenJ Russ Forney, Chansuda Wongsrichanalai, Alan J Magill, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 16, 2015
Effects of remote ischemic preconditioning in high-risk patients undergoing cardiac surgery (Remote IMPACT): a randomized controlled trialMichael Walsh, Richard Whitlock, Amit X Garg, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2016
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Lisa Beilke, Joel Bercu, et al.
Cancer|February 11, 2004
A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignanciesPaul J Hesketh, Francis Arena, Dhimant Patel, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Sequencing by Expansion (SBX) - a novel, high-throughput single-molecule sequencing technologyMark Kokoris, Robert McRuer, Melud Nabavi, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
The Lancet. Infectious Diseases|September 26, 2025
Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trialKirsten E Lyke, Andrea A Berry, Matthew B Laurens, et al.
Gynecologic Oncology|January 24, 2025
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258Aine Clements, Danielle Enserro, Kyle C Strickland, et al.
The Journal of Infectious Diseases|December 20, 2011
A simplified intravenous artesunate regimen for severe malariaPeter Gottfried Kremsner, Terrie Taylor, Saadou Issifou, et al.
The Lancet. Oncology|April 6, 2019
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trialKathleen N Moore, Angeles Alvarez Secord, Melissa A Geller, et al.
Mutagenesis|September 7, 2018
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?Alexander Amberg, Lennart T Anger, Joel Bercu, et al.
Journal of Clinical Microbiology|June 7, 2003
Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigenJ Russ Forney, Chansuda Wongsrichanalai, Alan J Magill, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 16, 2015
Effects of remote ischemic preconditioning in high-risk patients undergoing cardiac surgery (Remote IMPACT): a randomized controlled trialMichael Walsh, Richard Whitlock, Amit X Garg, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2016
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Lisa Beilke, Joel Bercu, et al.
Cancer|February 11, 2004
A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignanciesPaul J Hesketh, Francis Arena, Dhimant Patel, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Sequencing by Expansion (SBX) - a novel, high-throughput single-molecule sequencing technologyMark Kokoris, Robert McRuer, Melud Nabavi, et al.
Pageof 19